510(k) K023592
K023592 is an FDA 510(k) premarket notification submitted by Quest Intl., Inc. for the device "SERAQUEST ANTI-THYROGLOBULIN". The FDA issued a decision of Substantially Equivalent on January 6, 2003. The device falls under product code DDC (Thyroglobulin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5870. Quest Intl., Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 6, 2003
- Date Received
- October 25, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Thyroglobulin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5870
- Review Panel
- IM
- Submission Type